Table 2.
Clinical background of strains exhibiting different β-lactamase phenotypes
| |
|
Specimen-type |
Patient category |
Year of isolation |
||||
|---|---|---|---|---|---|---|---|---|
| Total | Stool | Urine | Blood | Inpatient | Outpatient | 1990s | 2000s | |
| NSBL |
278 |
153 (55) |
39 (14) |
86 (31) |
82 (29) |
196 (71) |
186 (67) |
91 (33) |
| IRT |
73 |
18 (25) |
38 (53) |
17 (22) |
60 (82) |
13 (18) |
28 (38) |
45 (62) |
| ESBL |
247 |
65(26) |
130 (53) |
52 (21) |
170 (69) |
77 (31) |
79 (32) |
168 (68) |
| CMT |
220 |
21 (10) |
163 (74) |
36 (16) |
163 (74) |
57 (26) |
62 (28) |
158 (72) |
| pAmpC | 94 | 13 (14) | 68 (72) | 13 (14) | 87 (92) | 7 (8) | 12 (13) | 82 (87) |
Number (%) of isolates exhibiting a given phenotype among those obtained from different specimen-types and different category of patients during the 1990s and 2000s period.